Active	Status	Sponsor type	Region	Phase	Filter
2 Active 0 Inactive 2 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Petrov, Petar
D1AMOND, NCT05615220: Ecopipam Tablets to Study Tourette's Disorder in Children, Adolescents and Adults	Recruiting	3	196	Europe, Canada, US, RoW	Ecopipam Hydrochloride	Emalex Biosciences Inc.	Tourette Disorder	12/24	12/24
NCT05729373: A Clinical Study That Will Measure How Well SEP-363856 Works and How Safe it is in Adults With Generalized Anxiety Disorder	Recruiting	2/3	434	Europe, Japan, US	SEP-363856, Placebo	Otsuka Pharmaceutical Development & Commercialization, Inc.	Generalized Anxiety Disorder	02/25	02/25